Maria Riedel

Arhus, Denmark

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

Haemodynamic control of zonated liver function via instructive vascular Wnt signalling.

Haemodynamic control of zonated liver function via instructive vascular Wnt signalling.

Journal: Nature communications
Published: February 03, 2026

CRISPR/Cas9 model of prostate cancer identifies Kmt2c deficiency as a metastatic driver by Odam/Cabs1 gene cluster expression.

CRISPR/Cas9 model of prostate cancer identifies Kmt2c deficiency as a metastatic driver by Odam/Cabs1 gene cluster expression.

Journal: Nature communications
Published: June 02, 2023

Targeting AP-1 transcription factors by CRISPR in the prostate.

Targeting AP-1 transcription factors by CRISPR in the prostate.

Journal: Oncotarget
Published: June 02, 2021

The CRISPR/Cas9 Minipig-A Transgenic Minipig to Produce Specific Mutations in Designated Tissues.

The CRISPR/Cas9 Minipig-A Transgenic Minipig to Produce Specific Mutations in Designated Tissues.

Journal: Cancers
Published: May 14, 2021

Comparative Analysis of Stk11/Lkb1 versus Pten Deficiency in Lung Adenocarcinoma Induced by CRISPR/Cas9.

Comparative Analysis of Stk11/Lkb1 versus Pten Deficiency in Lung Adenocarcinoma Induced by CRISPR/Cas9.

Journal: Cancers
Published: December 11, 2020

In vivo CRISPR inactivation of Fos promotes prostate cancer progression by altering the associated AP-1 subunit Jun.

In vivo CRISPR inactivation of Fos promotes prostate cancer progression by altering the associated AP-1 subunit Jun.

Journal: Oncogene
Published: December 10, 2020

A spatial vascular transcriptomic, proteomic, and phosphoproteomic atlas unveils an angiocrine Tie-Wnt signaling axis in the liver.

A spatial vascular transcriptomic, proteomic, and phosphoproteomic atlas unveils an angiocrine Tie-Wnt signaling axis in the liver.

Journal: Developmental cell
Published: November 10, 2020

FRMD6 has tumor suppressor functions in prostate cancer.

FRMD6 has tumor suppressor functions in prostate cancer.

Journal: Oncogene
Published: May 30, 2020

The cGAS-STING pathway is a therapeutic target in a preclinical model of hepatocellular carcinoma.

The cGAS-STING pathway is a therapeutic target in a preclinical model of hepatocellular carcinoma.

Journal: Oncogene
Published: January 29, 2019

Virus Delivery of CRISPR Guides to the Murine Prostate for Gene Alteration.

Virus Delivery of CRISPR Guides to the Murine Prostate for Gene Alteration.

Journal: Journal of visualized experiments : JoVE
Published: May 15, 2018

Neuropilin-1 mediates vascular permeability independently of vascular endothelial growth factor receptor-2 activation.

Neuropilin-1 mediates vascular permeability independently of vascular endothelial growth factor receptor-2 activation.

Journal: Science signaling
Published: April 28, 2016
Showing 1-11 of 11

Last Updated: 09/26/2026